Poly(anhydride-ester) fibers: Role of copolymer composition on hydrolytic degradation and mechanical properties

Journal of Biomedical Materials Research - Part A

Volumn 70, Issue 2, 2004, Pages 309-318

  Whitaker Brothers, Kenya ^a   Uhrich, Kathryn ^b  

^a The State University of New Jersey   (United States)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

Fibers; Hydrolytic degradation; Poly(anhydride ester); Surface erosion; Tensile modulus; Tensile strength

Indexed keywords

BIOCOMPATIBILITY; COPOLYMERIZATION; DEGRADATION; DRUG PRODUCTS; HYDROLYSIS; TENSILE STRENGTH; TOUGHNESS;

FIBER COMPOSITION; HYDROLYTIC DEGRADATION;

COPOLYMERS;

CARBOXYPHENOXYDECANOATE; COPOLYMER; POLYANHYDRIDE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED DRUG RELEASE; DEGRADATION; DRUG DELIVERY SYSTEM; FIBER; HYDROLYSIS; MECHANICAL STRESS; POLYMERIZATION; SURFACE PROPERTY; TENSILE STRENGTH; YOUNG MODULUS;

EID: 3343000040     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbm.a.30083     Document Type: Article

References (58)

1. Erdmann L, Uhrich K. Synthesis and degradation characteristics of salicylic acid-derived poly(anhydride-esters). Biomaterials 2000;21:1941-1946.
2. Levy G. Comparative pharmacokinetics of aspirin and acetaminophen. Arch Intern Med 1981;141:279-281.
3. Erdmann L, Macedo B, Uhrich K. Degradable poly(anhydride-ester) implants: effects of localized salicylic acid release on bone. Biomaterials 2000;21:2507-2512. 2512.
4. th Annual Meeting Trans Soc Biomater Apr 30-May 3, 2003.
5. Harten R, Svach D, Schmeltzer R, Uhrich K. Salicylic acid-derived poly(anhydride-esters) inhibit bone formation and resorption in vivo. Submitted for publication.
6. Schmeltzer R, Anastasiou T, Uhrich K. Optimized synthesis of salicylate-based poly(anhydride-esters). Polym Bull 2003;49:441-448.
7. Seidel J, Uhrich K, Laurencin C, Langer R. Erosion of poly(an-hydride-co-imides): a preliminary mechanistic study. J Appl Polym Sci 1996;62:1277-1283.
8. Uhrich K, Gupta A, Thomas T, Laurencin C, Langer R. Synthesis and characterization of degradable poly(anhydride-co-imides). Macromolecules 1995;28:2184-2193.
9. Uhrich K, Larrier D, Laurencin C, Langer R. In vitro degradation characteristics of poly(anhydride-imides) containing pyromellitylimidoalanine. J Polym Sci A Polym Chem 1996;34:1261-1269.
10. Uhrich K, Ibim S, Larrier D, Langer R, Laurencin C. Chemical changes during in vivo degradation of poly (anhydride-imide) matrices. Biomaterials 1998;19:2045-2050.
11. Wagner E, Uhrich K, Twardowski T. Processing considerations for salicylic acid-based polymeric prodrug fibers. Washington, DC: International Mechanical Engineering Congress; 2003. p 1-5.
12. Norkiewicz D, Breault L, Wonderlich S, Malone K. The use of chemotherapeutic agents in localized periodontal pockets. Mil Med 2001;166:940-946.
13. Schwach-Abdellaoui K, Vivien-Castioni N, Gurny R. Local delivery of antimicrobial agents for the treatment of periodontal diseases. Eur J Pharm Biopharm 2000;50:83-99.
14. Killoy W, Saiki S. A new horizon for the dental hygienist: controlled local delivery of antimicrobials. J Dent Hygiene 1999;73:84-93.
15. Cianco S. Site-specific delivery of antimicrobial agents for periodontal disease. Gen Den 1999;47:172-178.
16. Tonetti M, Cugini M, Goodson J. Zero-order delivery with periodontal placement of tetracycline-loaded ethylene vinyl acetate fibers. J Periodont Res 1990;25:243-249.
17. Litch J, Encarnacion M, Chen S, Leonard J, Burkoth T. Use of the polymeric matrix as internal standard for quantitation of in vivo delivery of tetracycline HCl from Actisite® tetracycline fiber during periodontal treatment. J Periodont Res 1996;31: 540-544.
18. Hanes J, Chiba M, Langer R. Degradation of porous poly(an-hydride-co- imide) microspheres and implications for controlled macromolecule delivery. Biomaterials 1998;19:163-172.
19. Uhrich K, Thomas T, Laurencin C, Langer R. In vitro degradation characteristics of poly(anhydride-imides) containing trim-ellitylimidoglycine. J Appl Polym Sci 1997;63:1401-1412.
20. Goepferich A, Schedl L, Langer R. The precipitation of mono-mers during the erosion of a class of polyanhydrides. Polymer 1996;37:3861-3869.
21. Uhrich K, Ibim S, Laurencin C, Langer R. Degradation of Poly(anhydride-co-imides): novel polymers for orthopedic applications. In: Mikos A, Leong K, Yaszemski M, Tamada J, Radomsky M, editors. Polymers in medicine and pharmacy. Pittsburgh: Materials Research Society; 1995. p 41-46.
22. Shieh L, Tamada J, Chen I, Pang J, Domb A, Langer R. Erosion of a new family of biodegradable polyanhydrides. J Biomed Mater Res 1994;28:1465-1475.
23. Shen E, Kipper M, Dziadul B, Lim M-K, Narasimhan B. Mechanistic relationships between polymer microstructure and drug release kinetics in bioerodible polyanhydrides. J Control Rel 2002;82:115-125.
24. Larobina D, Mensitieri G, Kipper M, Narasimhan B. Mechanistic understanding of degradation in bioerodible polymers for drug delivery. AlChE 2002;48:2960-2970.
25. Santos C, Freedman B, Leach K, Press D, Scarpulla M, Mathiowitz E. Poly(fumaric-co-sebacic anhydride). A degradation study as evaluated by FTIR, DSC, GPC, and X-ray diffraction. J Control Rel 1999;60:11-22.
26. Pekarek K, Dyrud M, Ferrer K, Jong Y, Mathiowitz E. In vitro and in vivo degradation of double-walled polymer microspheres. J Control Rel 1996;40:169-178.
27. Chickering D, Jacob J, Mathiowitz E. Bioadhesive microspheres. II. Characterization and evaluation of bioadhesion involving hard, bioerodible polymers and soft tissue. React Polym 1995;25:189-206.
28. Laurencin C, Domb A, Morris C, Brown V, Chasin M, McConnell R, Lange N, Langer R. Poly(anhydride) administration in high doses in vivo: Studies of biocompatibility and toxicology. J Biomed Mater Res 1990;24:1463-1481.
29. Goepferich A. Erosion of composite polymer matrices. Biomaterials 1997;18:397-403.
30. Shieh L, Göpferich A, Langer R. The erosion properties of polyanhydrides. Mater Res Soo Symp Proc; 1994. p 85-90.
31. Goepferich A, Tessmar J. Polyanhydride degradation and erosion. Adv Drug Del Rev 2002;54:911-913.
32. Goepferich A. Mechanisms of polymer degradation and erosion. Biomaterials 1996;17:103-114.
33. Uhrich K, Cannizzaro S, Langer R, Shakesheff K. Polymeric systems for controlled drug release. Chem Rev 1999;99:3181-3198.
34. Tabata Y, Gutta S, Langer R. Controlled delivery systems for proteins using polyanhydride microspheres. Pharm Res 1993;10:487-496.
35. Mathiowitz E, Langer R. Polyanhydride microspheres as drug carriers. 1. Hot melt microencapsulation. J Control Rel 1987;5:13-22.
36. Laurencin C, Gerhart T, Witschiger P, Satcher R, Domb A, Rosenberg A, Hanff P, Edsberg L, Hayes W, Langer R. Bioerodible polyanhydrides for antibiotic drug delivery: In vivo osteomyelitis treatment in a rat model system. J Orth Res 1993;11:256-262.
37. Mathiowitz E, Kline D, Langer R. Morphology of polyanhydride microsphere delivery systems. Scanning Microsc 1990;4:329-340.
38. Tamada J, Langer R. The development of polyanhydrides for drug delivery applications. J Biomater Sci Polym Ed 1992;31:1275-1285.
39. Howard M, Gross A, Grady M, Langer R, Mathiowitz E, Winn H, Mayberg M. Intracerebral drug delivery in rats with lesion-induced memory deficits. J Neurosurg 1989;71:105-112.
40. Anastasiou T, Uhrich K. Aminosalicylate-based biodegradable polymers: synthesis and in vitro characterization of poly(anhy-dride-esters) and poly(anhydride-amides). J Polym Sci A Polym Chem 2003;41:3667-3679.
41. Orloff L, Domb A, Teomim D, Fishbein I, Golomb G. Biodegradable implant strategies for inhibition of restenosis. Adv Drug Del Rev 1997;24:3-9.
42. Maniar M, Domb A, Haffer A, Shah J. Controlled-release of a local-anaesthetic from fatty-acid dimer based polyanhydride. J Control Rel 1994;30:233-236.
43. Kipper M, Shen E, Determan A, Narasimhan B. Design of an injectable system based on bioerodible polyanhydride microspheres for sustained drug delivery. Biomaterials 2002;23:4405-4412.
44. Dang W, Saltzman W. Dextran retention in the rat brain following release from a polymer implant. Biotechnol Prog 1992;8:527-532.
45. Dang W, Saltzman W. Controlled release of macromolecules from a degradable polyanhydride matrix. J Biomater Sci Polym Ed 1994;6:297-311.
46. Park E, Maniar M, Shah J. Biodegradable polyanhydride devices of cefazolin sodium, bupivacaine, and taxol for local drug delivery: preparation, and kinetics and mechanism of in vitro release. J Control Rel 1998;52:179-189.
47. Zhang T, Xu M, Chen H, Yu X. Synthesis, degradation, and drug delivery of cycloaliphatic poly(ester anhydride)s. J Appl Polym Sci 2002;86:2509-2514.
48. Vasheghani-Farahani E, Khorram M. Hydrophilic drug release from bioerodible polyanhydride microspheres. J Appl Polym Sci 2002;83:1457-1464.
49. Zhang T, Gu M, Yu X. Degradation and drug delivery properties of poly(1,4-cyclohexanedicarboxylic anhydride). J Biomater Sci Polym Ed 2001,12:491-501.
50. Brem H, Tamargo R, Olivi A, Pinn M, Weingart J, Wharam M, Epstein J. Biodegradable polymers for controlled delivery of chemotherapy with and without radiation therapy in the monkey brain. J Neurosurg 1994;80:283-290.
51. Vogelhuber W, Rotunno P, Magni E, Gazzaniga A, Spruss T, Bernhardt G, Buschauer A, Göpferich A. Programmable biodegradable implants. J Control Rel 2001;73:75-88.
52. Twardowski T, Wagner E, Whitaker K, Uhrich K. Melt extrusion of salicylic acid-based polymers. In preparation.
53. Akbari H, D'Emanuele A, Attwood D. Effect of fabrication technique on the erosion characteristics of polyanhydride matrices. Pharm Dev Technol 1998;3:251-259.
54. Goepferich A, Langer R. The influence of microstructure and monomer properties on the erosion mechanism of a class of polyanhydrides. J Polym Sci A Polym Chem 1993;31:2445-2458.
55. Erdmann L. Synthesis and medical applications of novel polymeric prodrugs (PhD). Piscataway, NJ: Rutgers University; 2001.
56. Nielsen L. Mechanical properties of polymers. New York: Reinhold Publishing; 1962. p 11-30.
57. 1% = 243 ± 97.4 Pa).
58. Sperling L. Introduction to physical polymer science. New York: John Wiley & Sons; 2001. 671 p.